NDA 216992 describes DEFLAZACORT, which is a drug marketed by
Biocon Pharma,
Sun Pharm Inds Inc,
Tris Pharma Inc,
Upsher Smith Labs,
Zydus Lifesciences,
Amneal,
Aurobindo Pharma Ltd,
Hikma, and
Sun Pharm, and is included in ten NDAs. It is available from
eight suppliers. Additional details are available on the
DEFLAZACORT profile page.
The generic ingredient in DEFLAZACORT is
deflazacort. There is one
drug master file entry for this compound. Twelve
suppliers are listed for this compound. Additional details are available on the
deflazacort profile page.